Aneta Płaza-Altamer

Dr. Aneta Płaza-Altamer

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
KOKrzysztof Ossoliński
Krzysztof Ossoliński
TRTomasz Ruman
Tomasz Ruman
Valerie CopieValerie Copie
Valerie Copie
BTBrian P. Tripet
Brian P. Tripet
LNLeonardo B. Nogueira
Leonardo B. Nogueira
Joanna NiziołJoanna Nizioł
Joanna Nizioł
Bladder cancer (BC) is one of the most frequently diagnosed types of urinary cancer. Despite advances in treatment methods, no specific biomarkers are currently in use. Targeted and untargeted profiling of metabolites and elements of human blood serum from 100 BC patients and the same number of normal controls (NCs), with external validation, was attempted using three analytical methods, i.e., nuclear magnetic resonance, gold and silver-109 nanoparticle-based laser desorption/ionization mass spectrometry (LDI-MS), and inductively coupled plasma optical emission spectrometry (ICP-OES). All results were subjected to multivariate statistical analysis. Four potential serum biomarkers of BC, namely, isobutyrate, pyroglutamate, choline, and acetate, were quantified with proton nuclear magnetic resonance, which had excellent predictive ability as judged by the area under the curve (AUC) value of 0.999. Two elements, Li and Fe, were also found to distinguish between cancer and control samples, as judged from ICP-OES data and AUC of 0.807 (in validation set). Twenty-five putatively identified compounds, mostly related to glycans and lipids, differentiated BC from NCs, as detected using LDI-MS. Five serum metabolites were found to discriminate between tumor grades and nine metabolites between tumor stages. The results from three different analytical platforms demonstrate that the identified distinct serum metabolites and metal elements have potential to be used for noninvasive detection, staging, and grading of BC.

25 August 2021 in ACS Measurement Science Au
Verified
Journal Article
Open access
APAneta Płaza-Altamer
Aneta Płaza-Altamer
AKArtur Kołodziej
Artur Kołodziej
JNJoanna Nizioł
Joanna Nizioł
TRTomasz Ruman
Tomasz Ruman
Preparation of monoisotopic silver-109 nanoparticles (109AgNPs) by pulsed fiber laser (PFL) ablation synthesis in solution (LASiS) with the use of a 2D galvoscanner (2D GS) is described. The procedure of covering of custom-made stainless-steel MALDI targets containing studied objects via nebulization is also presented. Examples of application of the new method (PFL-2D GS LASiS and nebulization) in mass spectrometry (MS) analyses and MS imaging (MSI) are shown. These include tests with a nonionic nucleoside and saccharide, ionic amino acids, and also a low-molecular-weight polymer. Fingerprint MS imaging is shown as an example of a fast and simple MSI procedure.

23 December 2022 in Advances in Medical Sciences
Verified
Journal Article
Closed access
KOKrzysztof Ossoliński
Krzysztof Ossoliński
TRTomasz Ruman
Tomasz Ruman
TOTadeusz Ossoliński
Tadeusz Ossoliński
AOAnna Ossolińska
Anna Ossolińska
Adrian ArendowskiAdrian Arendowski
Adrian Arendowski
Joanna NiziołJoanna Nizioł
Joanna Nizioł

31 August 2023 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
APAneta Płaza-Altamer
Aneta Płaza-Altamer
AKArtur Kołodziej
Artur Kołodziej
ZKZuzanna Krupa
Zuzanna Krupa
JNJoanna Nizioł
Joanna Nizioł
TRTomasz Ruman
Tomasz Ruman

13 May 2024 in Applied Spectroscopy Reviews
Verified
Journal Article
Closed access
APAneta Płaza-Altamer
Aneta Płaza-Altamer
AKArtur Kołodziej
Artur Kołodziej

7 February 2022 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
APAneta Płaza-Altamer
Aneta Płaza-Altamer
AKArtur Kołodziej
Artur Kołodziej
Joanna NiziołJoanna Nizioł
Joanna Nizioł
TRTomasz Ruman
Tomasz Ruman